SharonAI (NASDAQ: SHAZ) insider holds 1.3M shares under lock-up terms
Rhea-AI Filing Summary
Nicholas Hughes-Jones and an affiliated Australian trust report beneficial ownership of 1,299,158 SharonAI Holdings Class A shares, representing 8.1% of the class. These holdings are mainly through Inbocalupo Pty Ltd ATF Inbocalupo Trust, plus restricted stock units and other affiliated entities.
The stake includes 1,251,365 Class A shares held by the trust, 2,536 shares held by Defender Capital Pty Ltd, and 45,257 Class A shares underlying restricted stock units that are currently exercisable or will vest within 60 days of April 7, 2026. Hughes-Jones also holds 45,447 Class B Super Common shares via another entity.
Part of these holdings is subject to lock-up agreements: the trust is restricted from disposing of 50% of its Class A shares until June 15, 2026, while Hughes-Jones is restricted from disposing of all of his Class A shares until May 20, 2026. Some shares were received through a prior business combination and the conversion of preferred stock, common stock, convertible notes, and unsettled RSU awards.
Positive
- None.
Negative
- None.
Insights
Insider and affiliated trust disclose an 8.1% stake with lock-up limits.
The filing shows Nicholas Hughes-Jones, Head of Corporate Development at SharonAI Holdings Inc., and an affiliated Australian trust jointly beneficially owning 1,299,158 Class A shares, or 8.1% of that class as of late March/April 2026.
The position is largely held via Inbocalupo Pty Ltd ATF Inbocalupo Trust with 1,251,365 shares, plus 45,257 shares from restricted stock units expected to vest within 60 days of April 7, 2026. Additional economic interest comes from 45,447 Class B Super Common shares held through another entity.
A notable element is liquidity timing. The trust cannot dispose of 50% of its Class A holdings until June 15, 2026, and Hughes-Jones is restricted from selling any of his Class A shares until May 20, 2026. On March 23, 2026, 90,893 Class A shares were issued to the trust instead of a cash reimbursement, indicating the issuer sometimes settles obligations in equity.